BacterOMIC – massively parallel AST system

MICs for 80 antibiotics, FICs for 20 combinations, in a single test, in an automated format

BacterOmic delivers complete information on phenotypic antibiotic susceptibility of bacterial pathogens: MIC values for all antibiotics and synergies between up to 20 combinations. It enables precision therapies already after the first test.

Fastest access to information for targeted therapy

Technology:
  • Microbial diagnostics

Microorganisms:
  • Bacteria

Development stage:
  • Validation

Organization:
  • Company

Partnering:
  • Yes

We are happy to collaborate with any parties dedicated to fight AMR

BacterOmic founded in 2017 in Warsaw by Scope Fluidics is a project dedicated to provide doctors with information for precision therapies against AMR

N.A.


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!